Clinical Trials Browser

Phase 2 × Colorectal Neoplasms × Loperamide × Clear all

NCT04172597 2024-03-13

A Study of Poziotinib in Patients With Epidermal Growth Factor Receptor (EGFR) or Human Epidermal Growth Factor Receptor 2 (HER2) Activating Mutations in Advanced Malignancies

Phase 2 Terminated

1 enrolled 2 charts

BreastGastrointestinal

Breast Neoplasms, Colorectal Neoplasms